Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeMEDTRONIC plcMedtronic Announces Early Site Release of New Radial Artery Access Portfolio Following...

Medtronic Announces Early Site Release of New Radial Artery Access Portfolio Following First-in-Patient Procedure

February 1, 2021

Medtronic plc today announced expansion of its limited site release of the recently acquired radial artery access portfolio from privately-held RIST Neurovascular, Inc., which includes the Rist™ 079 Radial Access Guide Catheter and Rist™ Radial Access Selective Catheter. Terms of the acquisition were not disclosed.

“Rist 079 Radial Access Guide Catheter is the first catheter that has been specifically designed for neurointerventions using the radial artery pathway in the wrist. This is the first-of-its-kind device that optimizes transition zones for the required navigability and support that is unique to the radial trajectory when compared to the femoral approach,” said R. Webster Crowley, M.D., chief of Cerebrovascular and Endovascular Neurosurgery, Rush University Medical Center, who performed the first-in-patient procedure in September 2020.

He added, “The Rist Radial Access portfolio gives clinicians who perform neurovascular procedures the full spectrum of access and delivery devices that are optimized for the patient’s condition and anatomy. This should help improve the care we deliver to patients treated for neurovascular conditions.”

The addition of the Rist 079 Radial Access Guide Catheter and Selective Catheter to the Medtronic neurovascular portfolio enhances the company’s ability to serve patients that require interventional neurovascular therapy. Rist 079 Radial Access Guide Catheter and Rist Radial Access Selective Catheter received U.S. Food and Drug Administration (FDA) 501(k) clearance last year.1

“The Rist radial access portfolio is an ideal strategic fit for Medtronic as our goal is to offer the most advanced, patient-preferred delivery tools to meet the needs of neurovascular professionals,” said Stacey Pugh, president of the Neurovascular Therapies business, which is reported as part of the Restorative Therapies Group at Medtronic.

Pugh noted, “We are excited to announce that we have completed more than 80 cases in our limited market release evaluation at 12 institutions2 and are very pleased with performance and physician feedback. We also will be developing and expanding the portfolio to fully serve the broad patient population.”

Since 2018, the American Heart Association3 has recommended transradial techniques for cardiovascular endovascular interventions for acute coronary syndrome citing lower bleeding and vascular complications than transfemoral artery access. The neuro-interventionalist community is examining adoption of the transradial approach to their practice.

The acquisition of RIST Neurovascular, Inc., closed in August 2020 and is the eighth in a series of tuck-in acquisitions Medtronic has announced since January 2020. The revenue and earnings contribution is expected to be immaterial to the Medtronic Neurovascular business in the first two years and accretive thereafter. In addition, this transaction is expected to meet Medtronic’s long-term financial metrics for acquisitions.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy